Product Name :
Elenbecestat
Description:
Elenbecestat (E2609) is a potent, orally bioavailable and CNS-penetrant BACE-1 inhibitor. Elenbecestat has the potential for Alzheimer’s disease (AD) research.
CAS:
1388651-30-6
Molecular Weight:
437.44
Formula:
C19H18F3N5O2S
Chemical Name:
N-{3-[(4aS,5R,7aS)-2-amino-5-methyl-4H,4aH,5H,7H,7aH-furo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl}-5-(difluoromethyl)pyrazine-2-carboxamide
Smiles :
C[C@H]1OC[C@@]2(N=C(N)SC[C@@H]21)C1=CC(=CC=C1F)NC(=O)C1=CN=C(C=N1)C(F)F
InChiKey:
AACUJFVOHGRMTR-DPXNYUHVSA-N
InChi :
InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Elenbecestat (E2609) is a potent, orally bioavailable and CNS-penetrant BACE-1 inhibitor. Elenbecestat has the potential for Alzheimer’s disease (AD) research.|Product information|CAS Number: 1388651-30-6|Molecular Weight: 437.44|Formula: C19H18F3N5O2S|Chemical Name: N-{3-[(4aS,5R,7aS)-2-amino-5-methyl-4H,4aH,5H,7H,7aH-furo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl}-5-(difluoromethyl)pyrazine-2-carboxamide|Smiles: C[C@H]1OC[C@@]2(N=C(N)SC[C@@H]21)C1=CC(=CC=C1F)NC(=O)C1=CN=C(C=N1)C(F)F|InChiKey: AACUJFVOHGRMTR-DPXNYUHVSA-N|InChi: InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : ≥ 250 mg/mL (571.{{PAC} site|{PAC} Antibody-drug Conjugate/ADC Related|{PAC} Biological Activity|{PAC} Description|{PAC} supplier|{PAC} Autophagy} 51 mM).{{BAM 15} web|{BAM 15} Mitochondrial Metabolism|{BAM 15} Immunology/Inflammation|{BAM 15} Purity & Documentation|{BAM 15} Purity|{BAM 15} custom synthesis} |Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:32791892 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Elenbecestat (E2609) is a potent BACE1 inhibitor with an IC50 of ~7 nmol/L in cell-based assay. Elenbecestat has been shown to reduce Ab production in the plasma, brain, and cerebrospinal fluid (CSF) of rodents.|In Vivo:|Elenbecestat (E2609; 0.3-30 mg/kg; p.o.) potently inhibits Ab1-40 and Ab1-42 production in the plasma and CSF of non-human primates. Elenbecestat displays the plasma half-life of 12-16 hours after once daily dosing.|Products are for research use only. Not for human use.|
